Gepotidacin – Oral Products

	Minimum Inhibitory Concentrations (mcg/mL)			Disk Diffusion (zone diameter in mm)
Pathogen	S	I	R	S	I	R
Enterobacteralesa	≤ 16	32	≥ 64	≥ 12	8-11	≤ 7
Staphylococcus saprophyticus	≤0.25	-	-	≥ 23	-	-
Enterococcus faecalis	≤4	-	-	≥ 14

S = susceptible; I = intermediate; R = resistant
^a Clinical efficacy was shown for Escherichia coli, Klebsiella pneumoniae, and Citrobacter freundii complex.